June 23, 2026 · Form 4 insider transaction
Krop Julie sold 25,000 shares of Aquestive Therapeutics, Inc. at $5.02 per share, a transaction worth $125.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.